Mef2c plays oncogenic role in ALL, Acute Myeloid Leukemia (AML), colon adenocarcinoma, Diffuse Large B Cell Lymphoma (DLBCL), and T-cell lymphomas. Here, MEF2C is linked to acute myeloid leukemia.